Terms: = Liver cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Prognosis
16 results:
1. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
[TBL] [Abstract] [Full Text] [Related]
2. EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer.
D'Agostino D; Gentile R; Ponziani S; Di Vittorio G; Dituri F; Giannelli G; Rossi C; Marzullo L; Giansanti F; De Laurenzi V; Iacobelli S; Ippoliti R; Capone E; Sala G
Oncol Rep; 2021 Feb; 45(2):776-785. PubMed ID: 33416143
[TBL] [Abstract] [Full Text] [Related]
3. Epithelial V-like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB-PI3K-AKT pathway.
Ni Q; Chen Z; Zheng Q; Xie D; Li JJ; Cheng S; Ma X
Cancer Sci; 2020 May; 111(5):1500-1513. PubMed ID: 31997489
[TBL] [Abstract] [Full Text] [Related]
4. Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis.
Wu JB; Sarmiento AL; Fiset PO; Lazaris A; Metrakos P; Petrillo S; Gao ZH
World J Gastroenterol; 2019 Jul; 25(26):3408-3425. PubMed ID: 31341365
[TBL] [Abstract] [Full Text] [Related]
5. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/erbb3 signaling.
Shi DM; Li LX; Bian XY; Shi XJ; Lu LL; Zhou HX; Pan TJ; Zhou J; Fan J; Wu WZ
J Exp Clin Cancer Res; 2018 Nov; 37(1):294. PubMed ID: 30486894
[TBL] [Abstract] [Full Text] [Related]
6. Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer.
Gibson AJW; Li H; D'Silva A; Tudor RA; Elegbede AA; Otsuka SM; Bebb DG; Cheung WY
Med Oncol; 2018 Aug; 35(9):117. PubMed ID: 30073425
[TBL] [Abstract] [Full Text] [Related]
7. Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology.
Pellat A; Vaquero J; Fouassier L
Hepatology; 2018 Feb; 67(2):762-773. PubMed ID: 28671339
[TBL] [Abstract] [Full Text] [Related]
8. her3 expression is correlated to distally located and low-grade colon cancer.
Lédel F; Stenstedt K; Hallström M; Ragnhammar P; Edler D
Acta Oncol; 2016 Jul; 55(7):875-80. PubMed ID: 26863446
[TBL] [Abstract] [Full Text] [Related]
9. HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating erbb3.
Chen JY; Chen YJ; Yen CJ; Chen WS; Huang WC
Oncotarget; 2016 Jan; 7(1):473-89. PubMed ID: 26595522
[TBL] [Abstract] [Full Text] [Related]
10. The EGFR/erbb3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma.
Steinway SN; Dang H; You H; Rountree CB; Ding W
PLoS One; 2015; 10(5):e0128159. PubMed ID: 26000702
[TBL] [Abstract] [Full Text] [Related]
11. Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational status.
Lee J; Jain A; Kim P; Lee T; Kuller A; Princen F; In-GuDo ; Kim SH; Park JO; Park YS; Singh S; Kim HC
PLoS One; 2014; 9(8):e103551. PubMed ID: 25090459
[TBL] [Abstract] [Full Text] [Related]
12. The downregulation of erbb3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Hu B; Xiong Y; Ni R; Wei L; Jiang D; Wang G; Wu D; Xu T; Zhao F; Zhu M; Wan C
Mol Cell Biochem; 2014 Nov; 396(1-2):175-85. PubMed ID: 25081333
[TBL] [Abstract] [Full Text] [Related]
13. New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
Ross JS; Wang K; Gay L; Al-Rohil R; Rand JV; Jones DM; Lee HJ; Sheehan CE; Otto GA; Palmer G; Yelensky R; Lipson D; Morosini D; Hawryluk M; Catenacci DV; Miller VA; Churi C; Ali S; Stephens PJ
Oncologist; 2014 Mar; 19(3):235-42. PubMed ID: 24563076
[TBL] [Abstract] [Full Text] [Related]
14. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/her3 signalling.
De Boeck A; Pauwels P; Hensen K; Rummens JL; Westbroek W; Hendrix A; Maynard D; Denys H; Lambein K; Braems G; Gespach C; Bracke M; De Wever O
Gut; 2013 Apr; 62(4):550-60. PubMed ID: 22535374
[TBL] [Abstract] [Full Text] [Related]
15. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma.
Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF
Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584
[TBL] [Abstract] [Full Text] [Related]
16. Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.
Fuchs BC; Fujii T; Dorfman JD; Goodwin JM; Zhu AX; Lanuti M; Tanabe KK
Cancer Res; 2008 Apr; 68(7):2391-9. PubMed ID: 18381447
[TBL] [Abstract] [Full Text] [Related]
